Johnny C Akers1, Valya Ramakrishnan1, Isaac Yang2, Wei Hua3, Ying Mao3, Bob S Carter1,1, Clark C Chen1,1. 1. Center for Theoretical and Applied Neuro-Oncology, University of California, San Diego, CA, USA. 2. Department of Neurosurgery, University of California, Los Angeles, CA, USA. 3. Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Abstract
BACKGROUND: Tumor specific genetic material can be detected in extracellular vesicles (EVs) isolated from blood, cerebrospinal fluid (CSF), and other biofluids of glioblastoma patients. As such, EVs have emerged as a promising platform for biomarker discovery. However, the optimal procedure to transport clinical EV samples remains poorly characterized. METHODS: We examined the stability of EVs isolated from CSF of glioblastoma patients that were stored under different conditions. EV recovery was determined by Nanoparticle tracking analysis, and qRT-PCR was performed to determine the levels of miRNAs. RESULTS: CSF EVs that were lyophilized and stored at room temperature (RT) for seven days exhibited a 37-43% reduction in EV number. This reduction was further associated with decreased abundance of representative miRNAs. In contrast, the EV number and morphology remained largely unchanged if CSF were stored at RT. Total RNA and representative miRNA levels were well-preserved under this condition for up to seven days. A single cycle of freezing and thawing did not significantly alter EV number, morphology, RNA content, or miRNA levels. However, incremental decreases in these parameters were observed after two cycles of freezing and thawing. CONCLUSIONS: These results suggest that EVs in CSF are stable at RT for at least seven days. Repeated cycles of freezing/thawing should be avoided to minimize experimental artifacts.
BACKGROUND:Tumor specific genetic material can be detected in extracellular vesicles (EVs) isolated from blood, cerebrospinal fluid (CSF), and other biofluids of glioblastomapatients. As such, EVs have emerged as a promising platform for biomarker discovery. However, the optimal procedure to transport clinical EV samples remains poorly characterized. METHODS: We examined the stability of EVs isolated from CSF of glioblastomapatients that were stored under different conditions. EV recovery was determined by Nanoparticle tracking analysis, and qRT-PCR was performed to determine the levels of miRNAs. RESULTS: CSF EVs that were lyophilized and stored at room temperature (RT) for seven days exhibited a 37-43% reduction in EV number. This reduction was further associated with decreased abundance of representative miRNAs. In contrast, the EV number and morphology remained largely unchanged if CSF were stored at RT. Total RNA and representative miRNA levels were well-preserved under this condition for up to seven days. A single cycle of freezing and thawing did not significantly alter EV number, morphology, RNA content, or miRNA levels. However, incremental decreases in these parameters were observed after two cycles of freezing and thawing. CONCLUSIONS: These results suggest that EVs in CSF are stable at RT for at least seven days. Repeated cycles of freezing/thawing should be avoided to minimize experimental artifacts.
Authors: Johnny C Akers; Valya Ramakrishnan; Ryan Kim; Shirley Phillips; Vivek Kaimal; Ying Mao; Wei Hua; Isaac Yang; Chia-Chun Fu; John Nolan; Ichiro Nakano; Yuanfan Yang; Martin Beaulieu; Bob S Carter; Clark C Chen Journal: J Neurooncol Date: 2015-04-23 Impact factor: 4.130
Authors: Patryk Moskwa; Pascal O Zinn; Young Eun Choi; Sachet A Shukla; Wojciech Fendler; Clark C Chen; Jun Lu; Todd R Golub; Anita Hjelmeland; Dipanjan Chowdhury Journal: Mol Cancer Res Date: 2014-09-25 Impact factor: 5.852
Authors: Kimberly E Resnick; Hansjuerg Alder; John P Hagan; Debra L Richardson; Carlo M Croce; David E Cohn Journal: Gynecol Oncol Date: 2008-10-26 Impact factor: 5.482
Authors: Johnny C Akers; Valya Ramakrishnan; Ryan Kim; Johan Skog; Ichiro Nakano; Sandeep Pingle; Juliya Kalinina; Wei Hua; Santosh Kesari; Ying Mao; Xandra O Breakefield; Fred H Hochberg; Erwin G Van Meir; Bob S Carter; Clark C Chen Journal: PLoS One Date: 2013-10-21 Impact factor: 3.240
Authors: Deepa Kushwaha; Valya Ramakrishnan; Kimberly Ng; Tyler Steed; Thien Nguyen; Diahnn Futalan; Johnny C Akers; Jann Sarkaria; Tao Jiang; Dipanjan Chowdhury; Bob S Carter; Clark C Chen Journal: Oncotarget Date: 2014-06-30
Authors: Ganesh M Shankar; Leonora Balaj; Shannon L Stott; Brian Nahed; Bob S Carter Journal: Expert Rev Mol Diagn Date: 2017-09-06 Impact factor: 5.225
Authors: W Benton Swanson; Ting Gong; Zhen Zhang; Miranda Eberle; David Niemann; Ruonan Dong; Kunal J Rambhia; Peter X Ma Journal: J Control Release Date: 2020-06-10 Impact factor: 9.776
Authors: Javier M Figueroa; Johan Skog; Johnny Akers; Hongying Li; Ricardo Komotar; Randy Jensen; Florian Ringel; Isaac Yang; Steven Kalkanis; Reid Thompson; Lori LoGuidice; Emily Berghoff; Andrew Parsa; Linda Liau; William Curry; Daniel Cahill; Chetan Bettegowda; Frederick F Lang; E Antonio Chiocca; John Henson; Ryan Kim; Xandra Breakefield; Clark Chen; Karen Messer; Fred Hochberg; Bob S Carter Journal: Neuro Oncol Date: 2017-10-19 Impact factor: 12.300
Authors: Shannon N Tessier; Lauren D Bookstaver; Cindy Angpraseuth; Cleo J Stannard; Beatriz Marques; Uyen K Ho; Alona Muzikansky; Berent Aldikacti; Eduardo Reátegui; Daniel C Rabe; Mehmet Toner; Shannon L Stott Journal: PLoS One Date: 2021-05-13 Impact factor: 3.240